Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab.
Meoni G, Ghini V, Maggi L, Vignoli A, Mazzoni A, Salvati L, Capone M, Vanni A, Tenori L, Fontanari P, Lavorini F, Peris A, Bartoloni A, Liotta F, Cosmi L, Luchinat C, Annunziato F, Turano P.
Meoni G, et al. Among authors: cosmi l.
PLoS Pathog. 2021 Feb 1;17(2):e1009243. doi: 10.1371/journal.ppat.1009243. eCollection 2021 Feb.
PLoS Pathog. 2021.
PMID: 33524041
Free PMC article.